共 50 条
- [1] miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyJOURNAL OF UROLOGY, 2024, 212 (05): : 720 - 730Thor, AnnaMyklebust, Mette PernilleBergdahl, Anna GrenaboLundgren, Per-OlofSkokic, ViktorAlmas, BjarteHaugnes, Hege SagstuenTandstad, TorgrimAkre, OlofCohn-Cedermark, GabriellaDahl, OlavKjellman, Anders
- [2] Letter: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyJOURNAL OF UROLOGY, 2025, 213 (01): : 117 - 118Dieckmann, Klaus-PeterBelge, Gazanfer
- [3] Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissectionANDROLOGY, 2023, 11 (04) : 634 - 640Konneh, BenduLafin, John T.Howard, JeffreyGerald, ThomasAmini, ArmonSavelyeva, AnnaWoldu, Solomon L.Lewis, Cheryl M.Jia, LiweiMargulis, VitalyColeman, NicholasScarpini, CinziaFrazier, A. LindsayMurray, Matthew J.Amatruda, James F.Bagrodia, Aditya
- [4] Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancerANNALS OF ONCOLOGY, 2018, 29Nappi, L.Thi, M.Eigl, B. J.Lum, A.Huntsman, D.Martin, C.O'Neil, B.Khalaf, D. J.Chi, K. N.Gleave, M. E.So, A.Black, P.Daneshmand, S.Nichols, C. R.Kollmannsberger, C. K.
- [5] MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor PatientsINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)Terbuch, AngelikaAdiprasito, Jan B.Stiegelbauer, VerenaSeles, MaximilianKlec, ChristianePichler, Georg P.Resel, MargitPosch, FlorianLembeck, Anna L.Stoeger, HerbertSzkandera, JoannaPummer, KarlBauernhofer, ThomasHutterer, Georg C.Gerger, ArminStotz, MichaelPichler, Martin
- [6] Refining the serum miR-371a-3p test for viable germ cell tumor detectionSCIENTIFIC REPORTS, 2023, 13 (01)Lafin, John T.Scarpini, Cinzia G.Amini, ArmonKonneh, BenduHoward, Jeffrey M.Gerald, ThomasNuno, MichellePiao, JinSavelyeva, AnnaWang, ZhaohuiGagan, JeffreyJia, LiweiLewis, Cheryl M.Murray, SarahSawa, Yun C.Margulis, VitalyWoldu, Solomon L.Strand, Douglas W.Coleman, NicholasAmatruda, James F.Frazier, A. LindsayMurray, Matthew J.Bagrodia, Aditya
- [7] Refining the serum miR-371a-3p test for viable germ cell tumor detectionScientific Reports, 13John T. LafinCinzia G. ScarpiniArmon AminiBendu KonnehJeffrey M. HowardThomas GeraldMichelle NunoJin PiaoAnna SavelyevaZhaohui WangJeffrey GaganLiwei JiaCheryl M. LewisSarah MurrayYun C. SawaVitaly MargulisSolomon L. WolduDouglas W. StrandNicholas ColemanJames F. AmatrudaA. Lindsay FrazierMatthew J. MurrayAditya Bagrodia
- [8] EVALUATION OF MIR-371A-3P PERFORMANCE IN DETECTING SEMINOMATOUS TESTICULAR CANCER METASTASESJOURNAL OF UROLOGY, 2022, 207 (05): : E844 - E845Konneh, BenduLafin, John T.Savelyeva, AnnaWoldu, Solomon L.Lewis, CherylMargulis, VitalyFrazier, LindsayColeman, NicholasMurray, MatthewAmini, ArmonAmatruda, James F.Scarpini, CinziaBagrodia, Aditya
- [9] Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell CancerEUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 483 - 491Lobo, JoaoLeao, RicardoGillis, Ad J. M.van den Berg, AnnetteAnson-Cartwright, LynnAtenafu, Eshetu G.Kuhathaas, KopikaChung, PeterHansen, AaronBedard, Philippe L.Jewett, Michael A. S.Warde, PadraigO'Malley, MartinSweet, JoanLooijenga, Leendert H. J.Hamilton, Robert J.
- [10] Serum microRNA-371a-3p levels to predict viable germ cell tumor in chemotherapy-naive patients undergoing retroperitoneal lymph node dissectionJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)Singla, NirmishLafin, John T.Woldu, Solomon L.Lotan, YairLewis, CherylMajmudar, KuntalSavalyeva, AnnaKenigsberg, Alexander P.Kapur, PayalMargulis, VitalyStrand, DouglasMurray, MatthewAmatruda, James F.Bagrodia, Aditya